Dietary flavonoids: Bioavailability, metabolic effects, and safety

Annual Review of Nutrition

Volumn 22, Issue , 2002, Pages 19-34

  Ross, Julie A ^a   Kasum, Christine M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adverse effects; Catechins; Diet; Flavonoids; Quercetin

Indexed keywords

ANTHOCYANIDIN DERIVATIVE; ANTIESTROGEN; ANTIOXIDANT; APIGENIN; CATECHIN; CYANIDIN; DAIDZEIN; EPICATECHIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; GALLOCATECHIN; GENISTEIN; GLYCOSIDE; HESPERETIN; HESPERIDIN; ISOFLAVONE DERIVATIVE; LUTEOLIN; MYRICETIN; NARINGENIN; PELARGONIDIN; QUERCETIN; SCAVENGER; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STRUCTURE ANALYSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; DIET; EPIDEMIOLOGIC STUDIES; ESTROGEN RECEPTOR MODULATORS; FLAVANONES; FLAVONOIDS; FLAVONOLS; HUMANS; INTESTINAL ABSORPTION; ISOFLAVONES; NEOPLASMS; PHENOLS; POLYMERS; SAFETY;

EID: 0036400016     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.22.111401.144957     Document Type: Review

References (68)

1. Adlercruetz H, Markkanen H, Watanabe S. 1993. Plasma concentrations of phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 342:1209-10
2. Anderson RF, Amarasinghe C, Fisher LJ, Mak WB, Packer JE. 2000. Reduction in free-radical-induced DNA strand breaks and base damage through fast chemical repair by flavonoids. Free Radic. Res. 33:91-103
3. Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. 2000. Dietary intake of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL concentration. J. Nutr. 130:2243-50
4. Arts IC, Hollman PC, Bueno De Mesquita HB, Feskens EJ, Kromhout D. 2001. Dietary catechins and epithelial cancer incidence: The Zutphen elderly study. Int. J. Cancer 92:298-302
5. Bravo LB. 1998. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56:317-33
6. Croft KD. 1998. The chemistry and biological effects of flavonoids and phenolic acids. Ann. NY Acad. Sci. 854:435-42
7. De Stefani E, Boffetta P, Deneo-Pellegrini H, Mendilaharsu M, Carzoglio JC, et al. 1999. Dietary antioxidants and lung cancer risk: A case-control study in Uruguay. Nutr. Cancer 34:100-10
8. De Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, et al. 1998. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am. J. Clin. Nutr. 68:60-65
9. De Vries JH, Hollman PC, van Amersfoort I, Olthof MR, Katan MD. 2001. Red wine is a poor source of bioavailable flavonols in men. J. Nutr. 131:745-48
10. Dirven HAAM, van Ommen B, van Bladeren PJ. 1995. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res. 54:6215-20
11. Duthie G, Crozier A. 2000. Plant-derived phenolic antioxidants. Curr. Opin. Lipidol. 11:43-47
12. Duthie SJ, Johnson W, Dobson VL. 1997. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat. Res. 390:141-51
13. Felgines C, Texier O, Morand C, Manach C, Scalbert A, et al. 2000. Bioavailability of the flavanone naringenin and its glycosidese in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G1148-G54
14. Fiander H, Schneider H. 2000. Dietary ortho phenols that induce glutathione Stransferase and increase the resistance of cells to hydrogen peroxide are potential cancer chemopreventives that act by two mechanisms: The alleviation of oxidative stress and the detoxification of mutagenic xenobiotics. Cancer Lett. 156:17-24
15. World Cancer Res. Fund in association with Am. Inst. Cancer Res. 1997. Food, Nutrition and the Prevention of Cancer: A Global Perspective. New York: Am. Inst. Cancer Res.
16. Franke AA, Cooney RV, Custer LJ, Mordan LJ, Tanaka Y. 1998. Inhibition of neoplastic transformation and bioavailability of dietary flavonoid agents. In Flavonoids in the Living System, ed. JA Manthey, BS Buslig, pp. 237-48. New York: Plenum
17. Fremont L, Gozzelino MT, Franchi MP, Linard A. 1998. Dietary flavonoids reduce lipid peroxidation in rats fed polyunsaturated or monounsaturated fat diets. J. Nutr. 128:1495-502
18. Funabiki R, Takeshita K, Miura Y, Shibasato M, Nagasawa T. 1999. Dietary supplement of G-rutin reduces oxidative damage in the rodent model. J. Agric. Food Chem. 47:1076-82
19. Garcia-Closas R, Gonzalez CA, Agudo A, Riboli E. 1999. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control 10:71-75
20. Gerwirtz DA. 1991. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors? Biochem. Pharmacol. 42:2253-58
21. Gill WB. 1988. Effects on human males of in utero exposure to exogenous sex hormones. In Toxicity of Hormones in Perinatal Life, ed. T Mori, H Nagasawa, pp. 161-77. Boca Raton, FL: CRC
22. Goldbohm RA, van den Brandt PA, Hertog MGL, Brants HAM, van Poppel G. 1995. Flavonoid intake and risk of cancer: A prospective cohort study. Am. J. Epidemiol. 41:s61
23. Halliwell B. 1994. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 344:721-24
24. Hammerstone JF, Lazarus SA, Schmitz HH. 2000. Procyanidin content and variation in some commonly consumed foods. J. Nutr. 130:2086S-92
25. Harbourne JB. 1993. The Flavonoids: Advances in Research Since 1986. London: Chapman & Hall
26. Hertog MG, Feskens EJ, Hollm AN PC, Katan MB, Kromhout D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007-11
27. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, et al. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Int. Med. 155:381-86
28. Hertog MGL, Feskens EJM, Kromhout D. 1997. Antioxidant flavonols and coronary heart disease risk: Ten year follow-up of the Zutphen Elderly Study. Lancet 349:699
29. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. 1993. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer 20:21-29
30. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC, Kromhout D. 1997. Antioxidant flavonols and ischaemic heart disease in a Welsh population of men. The Caerphilly Study. Am. J. Clin. Nutr. 65:1489-94
31. Hollman PC, Katan MB. 1999. Dietary flavonoids: Intake, health effects, and bioavailability. Food Chem. Toxicol. 37:937-42
32. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. 1995. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62:1276-82
33. Hollman PCH, van Trijp JMP, Buysman NCP, van der Gaag MS, Mengelers MJB, et al. 1997. Relative bioavailibility of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 418:152-56
34. Hollman PCH, Katan MB. 1999. Health effects and bioavailability of dietary flavonols. Free Radic. Res. 31:S75-80
35. Ibrahim AR, Abul-Hajj YJ. 1990. Aromatase inhibition by flavonoids. J. Steroid Biochem. Mol. Biol. 37:257-60
36. Ioku K, Tsushida T, Takei Y, Nakatani N, Terao J. 1995. Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochim. Biophys. Acta 1234:99-104
37. Keli SO, Hertog MG, Feskens EJM, Kromhout D. 1996. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: The Zutphen Study. Arch. Int. Med. 156:637-42
38. Kellis JT, Vickery LE. 1984. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225:1032-34
39. Knekt P, Isotupa S, Rissanen H, Heliovaara M, Jarvinen R, et al. 2000. Quercetin intake and the incidence of cerebrovascular disease. Eur. J. Clin. Nutr. 54:415-17
40. Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: A cohort study. Br. Med. J. 312:478-81
41. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, et al. 1997. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol. 146:223-30
42. Kuhnau J. 1976. The flavonoids: A class of semi-essential food components: Their role in human nutrition. World Rev. Nutr. Diet 24:117-91
43. Kuntz S, Wenzel U, Daniel H. 1999. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur. J. Nutr. 38:133-42
44. Kuo SM. 1997. Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit. Rev. Oncogen. 8:47-69
45. Leth T, Justesen U. 1998. Analysis of flavonoids in fruits, vegetables and beverages by HPCL-UV and LC-MS and estimation of the total daily flavonoid intake in Denmark. In Polyphenols in Food, ed. R Amado, H Andersson, S Bardocz, F Serra, pp. 39-40. Luxembourg: Off. Official Publications Eur. Commun.
46. Lien EJ, Ren SI, Bui HUH, Wang RB. 1999. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radic. Biol. Med. 26:285-94
47. Makela S, Poutanen M, Kostian ML, Lehtimaki N, Salo L, et al. 1995. Inhibition of 17B-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. 3rd Int. Conf. Phytoestrogens. Dec. 3-6, Little Rock, AK
48. Mao TK, Powell JJ, van de Water J, Keen CL, Schmitz HH, Gershwin ME. 1999. The influence of cocoa procyanidins on the transcription of interleukin-2 in peripheral blood mononuclear cells. Int. J. Immunother. 15:23-29
49. McAnlis GT, McEneny J, Pearce J, Young IS. 1997. The effect of various dietary flavonoids on the susceptibility of low density lipoproteins to oxidation in vitro using both metallic and non-metallic oxidizing agents. Biochem. Soc. Transactions (25):142S
50. Miksicek RJ. 1995. Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med. 208:44-50
51. Moon J-H, Nakata R, Oshima S, Inakuma T, Terao J. 2000. Accumulation of quercetin conjugates in blood plasma after the short term ingestion of onion by women. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 279:R461-67
52. Ness AR, Powles JW. 1997. Fruits and vegetables, and cardiovascular disease: A review. Int. J. Epidemiol. 26:1-13
53. Newbold RR, Banks EP, Bullock B, Jefferson WN. 2001. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 61:4325-28
54. Nielsen SE, Young JF, Daneshvar B, Lauridsen ST, Knuthsen P, et al. 1999. Effect of parsley intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subject. Br. J. Nutr. 81:447-55
55. Noroozi M, Angerson WJ, Lean MEJ. 1998. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr. 67:1210-18
56. Paolini M, Cantelli-Forti G, Perocco P, Pedulli GF, Abdel-Rahman SZ, Legator MS. 1999. Co-carcinogenic effect of B-carotene. Nature 398:760-61
57. Rimm EG, Katan MB, Ascherio A, Stampfer MJ, Willett WC. 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med. 125:384-89
58. Ross JA. 1998. Maternal diet and infant leukemia: A role for DNA topoisomerase II inhibitors? Int. J. Cancer 11:26-28
59. Rusznyak SP, Szent-Gyorgyi A. 1936. Vitamin P: Flavonols as vitamins. Nature 138:27
60. Safe S. 1995. Environmental and dietary estrogens and human health: Is there a problem? Environ. Health Perspect. 103:346-51
61. Scalbert A, Williamson G. 2000. Dietary intake and bioavailibility of polyphenols. J. Nutr. 130:2073S-85S
62. Setchell KDR, Zimmer-Nechemias L, Cai J, Heubi JE. 1997. Exposure of infants to phytoestrogens from soy-based formula. Lancet 350:23-27
63. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. 97:4794-95
64. Terao J. 1999. Dietary flavonoids as antioxidants in vivo: Conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma. J. Med. Invest. 46:159-68
65. Wenzel U, Kuntz S, Brendel MD, Daniel H. 2000. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 60:3823-31
66. Xu X, Harris KS, Wang HJ, Murphy PA, Hendrich S. 1995. Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125:2307-15
67. Xu X, Wang HJ, Murphy PA, Cook L, Hendrich S. 1994. Daidzein is more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124:825-32
68. Yochum L, Kushi LH, Meyer K, Folsom AR. 1999. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol. 149:943-49